封面
市场调查报告书
商品编码
1392329

全球灌注系统市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

Global Perfusion System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

全球灌注系统市场需求预计将从 2022 年的 42.4 亿美元达到 2030 年近 76.8 亿美元的市场规模,2023-2030 年研究期间CAGR为 6.82%。

灌注系统是用于在手术期间将含氧血液输送到身体的装置。灌注系统用于心臟手术,灌注专家透过使用人工血泵向患者註入血液,在心臟外科医生手术时取代心臟的功能。灌注系统也用于化疗,以治疗手臂或腿部的黑色素瘤。灌注系统技术暂时停止肢体中的血流,将抗癌药物直接注射到肢体的血液中。器官移植手术使用灌注系统,因为它们透过将血液泵送到全身来帮助在手术过程中替代器官的功能。

市场动态:

随着全球心血管和呼吸系统疾病盛行率的不断上升,全球灌注系统市场可能会成长。此外,饮食不当、吸烟和饮酒也会导致器官衰竭,这导致了对有效灌注系统的需求。此外,灌注系统市场也受到製药和生物技术产业显着成长的推动。此外,技术发展为未来几年的市场成长提供了重大机会。然而,发展中国家对灌注系统缺乏认识可能会限制该市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球灌注系统市场的各个细分市场进行了包容性评估。灌注系统产业的成长和趋势为本研究提供了整体方法。

区域分析:

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲灌注系统市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。灌注系统市场的主要参与者包括 Getinge AB、Medtronic plc、LivaNova、Terumo Corporation、Nipro Corporation、XENIOS AG、Repligen Corporation、Spectrum Laboratories Inc.、Merck KGaA、Harvard Bioscience Inc.、ALA Scientific Instruments, Inc.、Lifeline科学公司、XVIVO 灌注公司。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:灌注系统 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:COVID-19 爆发的影响分析

第 6 章:全球灌注系统市场分析:依应用分类

  • 概述:按应用
  • 历史和预测数据
  • 分析:按应用
  • 心肺灌注系统(制氧机、心肺机、灌注帮浦、插管、监护系统等)
  • 细胞灌流系统(生物反应器灌流系统、微流控灌流系统、重力/压力驱动灌流系统、小型哺乳动物器官灌流系统)
  • 离体器官灌注系统(低温、常温)

第 7 章:全球灌注系统市场分析:以地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:灌注系统公司的竞争格局

  • 灌注系统市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Getinge AB
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medtronic plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • LivaNova
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Terumo Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nipro Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • XENIOS AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Repligen Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Spectrum Laboratories Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Harvard Bioscience Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ALA Scientific Instruments Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lifeline Scientific Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • XVIVO Perfusion AB
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR11218522

The global demand for Perfusion System Market is presumed to reach the market size of nearly USD 7.68 BN by 2030 from USD 4.24 BN in 2022 with a CAGR of 6.82% under the study period 2023 - 2030.

Perfusion system is a device used to deliver oxygenated blood to the body during surgery. Perfusion systems are used in heart surgeries where perfusion experts thrust patients' blood by employing artificial blood pumps, which replace the heart's function while the cardiac surgeon operates. Perfusion systems are also used in chemotherapy for the treatment of melanoma present in the arm or legs. Perfusion system technique temporarily stops blood flow in the limb, allowing anticancer drugs to be injected directly into the limb's blood. Organ transplant surgeries use perfusion systems as they help replace the organ's function during the operation by pumping blood throughout the body.

MARKET DYNAMICS:

The global perfusion system market is likely to grow with the increasing prevalence of cardiovascular and respiratory diseases across the globe. Moreover, improper diet, smoking and consumption of alcohol also leads to organ failure, which has led to the demand for effective perfusion systems. Furthermore, the perfusion systems market is also driven by the significant growth of the pharmaceutical and biotechnology industries. Additionally, technological development holds a significant opportunity for market growth in the coming years. However, a lack of awareness regarding perfusion systems in developing countries can limit the growth of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of perfusion system. The growth and trends of perfusion system industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the perfusion system market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Cardiopulmonary Perfusion System (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-Driven Perfusion System, Small Mammal Organ Perfusion System)
  • Ex-Vivo Organ Perfusion System (Hypothermic, Normothermic)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Perfusion System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Perfusion System market include Getinge AB, Medtronic plc, LivaNova, Terumo Corporation, Nipro Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories Inc., Merck KGaA, Harvard Bioscience Inc., ALA Scientific Instruments, Inc., Lifeline Scientific Inc, XVIVO Perfusion AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PERFUSION SYSTEM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERFUSION SYSTEM MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Historic and Forecast Sales by Regions
  • 6.5 Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Historic and Forecast Sales by Regions
  • 6.6 Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Historic and Forecast Sales by Regions

7 . GLOBAL PERFUSION SYSTEM MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PERFUSION SYSTEM COMPANIES

  • 8.1. Perfusion System Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PERFUSION SYSTEM INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Getinge AB
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Medtronic plc
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. LivaNova
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Nipro Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. XENIOS AG
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Repligen Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Spectrum Laboratories Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Merck KGaA
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Harvard Bioscience Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. ALA Scientific Instruments Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Lifeline Scientific Inc
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. XVIVO Perfusion AB
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Application (USD MN)
  • Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Market Sales by Geography (USD MN)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Market Sales by Geography (USD MN)
  • Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Market Sales by Geography (USD MN)
  • Global Perfusion System Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Perfusion System Report
  • Market Research Process
  • Market Research Methodology
  • Global Perfusion System Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Cardiopulmonary Perfusion System (Oxygenators, Heart-lung Machine, Perfusion Pumps, Cannula, Monitoring System, Others) Market Sales by Geography (USD MN)
  • Cell Perfusion System (Bioreactor Perfusion System, Microfluidic Perfusion System, Gravity/Pressure-driven Perfusion System, Small Mammal Organ Perfusion System) Market Sales by Geography (USD MN)
  • Ex-vivo Organ Perfusion System (Hypothermic, Normothermic) Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.